On May 20, according to the official website of the Center for Tobacco Products (CTP) of the US Food and Drug Administration (FDA), Dr. Bret Koplow has been appointed as the Acting Director of the Center for Tobacco Products.
Resume information indicates that Dr. Brett Koplow was appointed as Acting Director of the Center for Tobacco Products (CTP) at the Food and Drug Administration in May 2025. In this role, Dr. Coplow is responsible for ensuring that the CTP achieves its public health goals and puts into practice the center's vision and mission in implementing the Family Smoking Prevention and Tobacco Control Act.
According to Bloomberg, FDA Commissioner Marty Makary stated in an internal email that senior FDA official Bret Koplow will temporarily assume the position.
According to Koplow' s LinkedIn page, he has been working at the FDA since 2011. Within the agency, he has held various positions, most recently serving as a senior advisor to the FDA Commissioner.
In April, the United States Department of Health and Human Services (HHS), under the leadership of Robert Kennedy Jr., carried out a large-scale layoff, resulting in the dismissal of Brian King, who was the Director of the Center for Tobacco Products (CTP) at the time. In May, The Campaign for Tobacco-Free Kids announced on its official website that Brian King had been appointed as the Executive Vice President for the U.S. program, tasked with leading the organization's efforts at the federal, state, and local levels.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
